347 related articles for article (PubMed ID: 11034934)
1. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
Sacks FM; Alaupovic P; Moye LA; Cole TG; Sussex B; Stampfer MJ; Pfeffer MA; Braunwald E
Circulation; 2000 Oct; 102(16):1886-92. PubMed ID: 11034934
[TBL] [Abstract][Full Text] [Related]
2. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
Lee SJ; Campos H; Moye LA; Sacks FM
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):853-8. PubMed ID: 12637336
[TBL] [Abstract][Full Text] [Related]
3. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
Chiuve SE; Martin LA; Campos H; Sacks FM
J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
[TBL] [Abstract][Full Text] [Related]
4. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.
Luc G; Fievet C; Arveiler D; Evans AE; Bard JM; Cambien F; Fruchart JC; Ducimetiere P
J Lipid Res; 1996 Mar; 37(3):508-17. PubMed ID: 8728314
[TBL] [Abstract][Full Text] [Related]
5. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
[TBL] [Abstract][Full Text] [Related]
6. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
[TBL] [Abstract][Full Text] [Related]
7. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content.
Khoo C; Campos H; Judge H; Sacks FM
J Lipid Res; 1999 Feb; 40(2):202-12. PubMed ID: 9925648
[TBL] [Abstract][Full Text] [Related]
9. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Chan DC; Watts GF; Nguyen MN; Barrett PH
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
[TBL] [Abstract][Full Text] [Related]
10. Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo.
Bach-Ngohou K; Nazih H; Nazih-Sanderson F; Zaïr Y; Le Carrer D; Krempf M; Bard JM
Int J Obes Relat Metab Disord; 2001 Dec; 25(12):1752-8. PubMed ID: 11781754
[TBL] [Abstract][Full Text] [Related]
11. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine.
Hasler-Rapacz J; Kempen HJ; Princen HM; Kudchodkar BJ; Lacko A; Rapacz J
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):137-43. PubMed ID: 8548414
[TBL] [Abstract][Full Text] [Related]
12. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ
Kidney Int; 2000 Sep; 58(3):1238-46. PubMed ID: 10972686
[TBL] [Abstract][Full Text] [Related]
13. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor.
Bisgaier CL; Essenburg AD; Barnett BC; Auerbach BJ; Haubenwallner S; Leff T; White AD; Creger P; Pape ME; Rea TJ; Newton RS
J Lipid Res; 1998 Jan; 39(1):17-30. PubMed ID: 9469582
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.
Campos H; Perlov D; Khoo C; Sacks FM
J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625
[TBL] [Abstract][Full Text] [Related]
15. Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease.
Lee SJ; Moye LA; Campos H; Williams GH; Sacks FM
Atherosclerosis; 2003 Apr; 167(2):293-302. PubMed ID: 12818412
[TBL] [Abstract][Full Text] [Related]
16. Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus.
Lee SJ; Sacks FM
Am J Cardiol; 2003 Jul; 92(2):121-4. PubMed ID: 12860210
[TBL] [Abstract][Full Text] [Related]
17. VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins.
Balling M; Afzal S; Varbo A; Langsted A; Davey Smith G; Nordestgaard BG
J Am Coll Cardiol; 2020 Dec; 76(23):2725-2735. PubMed ID: 33272366
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
Mendivil CO; Zheng C; Furtado J; Lel J; Sacks FM
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):239-45. PubMed ID: 19910636
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.
Sacks FM; Moyé LA; Davis BR; Cole TG; Rouleau JL; Nash DT; Pfeffer MA; Braunwald E
Circulation; 1998 Apr; 97(15):1446-52. PubMed ID: 9576424
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells.
Kawakami A; Aikawa M; Libby P; Alcaide P; Luscinskas FW; Sacks FM
Circulation; 2006 Feb; 113(5):691-700. PubMed ID: 16461842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
